Heilpflanzenwohl AG

HPW Pharma develops chemical-free drugs and supplements in selected therapeutic areas (chronic pain, cardiovascular&metabolism). They are a pure-play, chemical-free OTC consumer health company with leading brands for natural, systemic drugs in the market for Diabetes, Obesity, Osteoarthritis, back pain and neuralgic and nociceptive pain. With their products HPW Pharma primarily targets the out-of-the-pocket pharmaceutical market, especially elderly customers with chronic conditions who prefer chemical-free drugs in order to reduce the risk of side-effects. HPW Pharma creates strong brands and uses a unique data driven D2C marketing strategy which supports their premium price strategy. They are a leading German player in the market for chemical-free drugs.

HPW Story:
HPW Pharma ranks among the Top 50 OTC Pharmacos in the German market and the Top 15 for all natural OTC drugs according to IQVIA in 2019.
HPW Pharma is with > 70% growth in 2019 the fastest growing OTC in Germany and has been awarded the # 1 OTC company in 2019.
Focus on chemical-free OTC drugs and supportive consumer trends allow premium pricing and attractive margins
Leading brands in the chemical-free consumer healthcare trend
> 10 product launches in 2017-2020, driving above market-growth. Many best in class launches with a substantial percentage of repeat usage.
Short time to market due to streamlined launch algorithm and lean approval process, since there is no need for clinical studies
D2C marketing creates Pull effect: driven by an unique pull playbook base on best in class media buying terms, unique ad execution, top notch digital know how and an unparalleled commercial and analytical toolbox
HPW has a balanced Portfolio of registered OTC drugs with strong promotional claims, unique Phyto Products, Med Devices and NEM and owns the full IP on these brands.
The HPW has an industry leading pipeline with > 20 projects